The US Food & Drug Administration (FDA) recently fast tracked the approval process of a promising treatment for Metastatic Melanoma following the publication of the results of a study conducted at the John Theurer Cancer Center at the Hackensack University Medical Center in New Jersey. The FDA accepted an application for the approval of Ipilimumab [...]